During the past decade, MD Anderson Cancer Center at Cooper-Voorhees conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 29 clinical trials were completed, i.e. on average, 52.7% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 21 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MD Anderson Cancer Center at Cooper-Voorhees" #1 sponsor was "National Cancer Institute (NCI)" with 28 trials, followed by "Radiation Therapy Oncology Group" with 13 trials sponsored, "M.D. Anderson Cancer Center" with 6 trials sponsored, "NRG Oncology" with 6 trials sponsored and "The Cooper Health System" with 6 trials sponsored. Other sponsors include 42 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MD Anderson Cancer Center at Cooper-Voorhees" #1 collaborator was "National Cancer Institute (NCI)" with 47 trials as a collaborator, "NRG Oncology" with 19 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Bayer" with 2 trials as a collaborator and "Canadian Cancer Trials Group" with 2 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "MD Anderson Cancer Center at Cooper-Voorhees" are "Prostate Cancer" (8 trials), "Fallopian Tube Clear Cell Adenocarcinoma" (6 trials), "Fallopian Tube Transitional Cell Carcinoma" (6 trials), "Ovarian Clear Cell Adenocarcinoma" (6 trials) and "Ovarian Seromucinous Carcinoma" (6 trials). Many other conditions were trialed in "MD Anderson Cancer Center at Cooper-Voorhees" in a lesser frequency.

Most popular intervention types in "MD Anderson Cancer Center at Cooper-Voorhees" are "Drug" (81 trials), "Other" (49 trials), "Radiation" (40 trials), "Biological" (26 trials) and "Procedure" (21 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (27 trials), "Laboratory Biomarker Analysis" (21 trials), "Paclitaxel" (19 trials), "Questionnaire Administration" (17 trials) and "Carboplatin" (12 trials). Other intervention names were less common.

The vast majority of trials in "MD Anderson Cancer Center at Cooper-Voorhees" are 61 trials for "All" genders, 34 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "MD Anderson Cancer Center at Cooper-Voorhees". undefined are not yet recruiting, 28 are recruiting, 40 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in MD Anderson Cancer Center at Cooper-Voorhees, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in MD Anderson Cancer Center at Cooper-Voorhees, 6 "Phase 1" clinical trials were conducted, 32 "Phase 2" clinical trials and 66 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".